Jon H. Condra

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

Roy M. Gulick, John W. Mellors, Diane V. Havlir et al. · New England Journal of Medicine · 1997 · 1.9K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

Jon H. Condra, William A. Schleif, O M Blahy et al. · Nature · 1995 · 979 citations

Life Sciences, Infectious Diseases, Molecular Biology +16

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

Jon H. Condra, Daniel Holder, William A. Schleif et al. · Journal of Virology · 1996 · 405 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

Xiaoping Liang, Melanie Horton, Helen C. Perry et al. · Vaccine · 2004 · 315 citations

Veterinary Medicine, Immunology, Infectious Diseases +13

5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase

Theresa M. Williams, Terrence M. Ciccarone, Suzanne C. MacTough et al. · Journal of Medicinal Chemistry · 1993 · 267 citations · Full text

Medicine, Chemistry, Pharmacology +13